Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03102138

Retinal Pigment Epithelium Safety Study for Patients in B4711001

Long Term, Open-Label, Safety Follow Up Study Following Transplantation of Pf-05206388 (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)) in Subjects with Acute Wet Age Related Macular Degeneration and Recent Rapid Vision Decline

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Moorfields Eye Hospital NHS Foundation Trust · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

This is a safety follow-up study. Patients enrolled in B4711001 will be followed for a further 4 years with regular visits to assess safety.

Conditions

Timeline

Start date
2024-04-16
Primary completion
2027-05-30
Completion
2028-06-30
First posted
2017-04-05
Last updated
2024-11-22

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03102138. Inclusion in this directory is not an endorsement.

Retinal Pigment Epithelium Safety Study for Patients in B4711001 (NCT03102138) · Clinical Trials Directory